Hepatic Cell News Volume 4.24 | Jul 3 2020

    By
    Justin.choi
    -
    0
    17







    2020-03-07 | HCN 4.24


    Hepatic Cell News by STEMCELL Technologies
    Vol. 4.24 – 3 July, 2020
    TOP STORY

    miR‐125b Loss Activated HIF1α/pAKT Loop, Leading to Trans‐Arterial Chemoembolization Resistance in Hepatocellular Carcinoma

    Scientists aimed to identify key molecular signatures and related pathways leading to hepatocellular carcinoma resistance to trans‐arterial chemoembolization (TACE), with the hope of developing effective approaches in pre‐selecting patients with survival benefit from TACE.
    [Hepatology]

    Abstract

    How to prioritize and manage your research projects
    PUBLICATIONSRanked by the impact factor of the journal

    Attenuating the EGFR‐ERK‐SOX9 Axis Promotes Liver Progenitor Cell‐Mediated Liver Regeneration in Zebrafish

    Researchers found that suppression of EGFR signaling promoted liver progenitor cell‐to‐hepatocyte differentiation via the MEK‐ERK‐SOX9 cascade.
    [Hepatology]

    Abstract

    Doublecortin-Like Kinase 1 Promotes Hepatocyte Clonogenicity and Oncogenic Programming via Non-Canonical β-Catenin-Dependent Mechanism

    Spheroids derived from doublecortin-like kinase 1 (DCLK1)-overexpressing hepatoma cells showed high level expression of active β-catenin, α-fetoprotein, and SOX9, suggesting that DCLK1 overexpression induced clonogenicity and dedifferentiated phenotypes in hepatoma cells.
    [Scientific Reports]

    Full Article

    Decreased miR-200b-3p in Cancer Cells Leads to Angiogenesis in HCC by Enhancing Endothelial ERG Expression

    Researchers investigated whether hepatocyte-derived miR-200b-3p governed angiogenesis in hepatocellular carcinoma (HCC) by targeting endothelial erythroblast transformation-specific-related gene (ERG).
    [Scientific Reports]

    Full Article

    Hepatic Stellate Cell-Specific Platelet-Derived Growth Factor Receptor α Loss Reduces Fibrosis and Promotes Repair following Hepatocellular Injury

    While no major difference was observed after bile duct ligation or 3,5-diethoxycarbonyl-1,4-dihydrocollidine, platelet-derived growth factor receptor α loss in hepatic stellate cells (HSCs) led to a significant albeit transient reduction in fibrosis after CCl4 injury, associated with increased HSC death and reduced migration.
    [American Journal of Pathology]

    Abstract

    MicroRNA-375 Represses Tumor Angiogenesis and Reverses Resistance to Sorafenib in Hepatocarcinoma

    The authors identified that the expression of the tumor-suppressive miRNA miR-375 was significantly induced in hepatoma cells treated with sorafenib, and miR-375 could exert its antiangiogenic effect partially via platelet-derived growth factor C inhibition.
    [Cancer Gene Therapy]

    Full Article

    Human Hepatic In Vitro Models Reveal Distinct Anti-NASH Potencies of PPAR Agonists

    Investigators reproduced key non-alcoholic steatohepatitis (NASH) characteristics in vitro by exposing primary human hepatocytes, human skin stem cell-derived hepatic cells, HepaRG and HepG2 cell lines, as well as LX-2 cells to multiple factors that play a role in the onset of NASH.
    [Cell Biology and Toxicology]

    Abstract

    Fibrillar Collagen Type I Participates in the Survival and Aggregation of Primary Hepatocytes Cultured on Soft Hydrogels

    Researchers evaluated the role of fibrillar collagens and basement membrane-associated matrix on actin cytoskeleton organization and the function of rat primary hepatocytes cultured on soft elastic polyacrylamide hydrogels.
    [Bioinspiration & Biomimetics]

    Abstract

    A Licorice Roots Extract Induces Apoptosis and Cell Cycle Arrest and Improves Metabolism via Regulating MiRNAs in Liver Cancer Cells

    Scientists investigated the effect of licorice roots extract on some metabolic pathways and their regulating miRNAs in hepatocellular carcinoma cells.
    [Nutrition and Cancer-An International Journal]

    Abstract

    Watch 'collaborating to accelerate COVID-19 research'
    REVIEWS

    Induced Pluripotent Stem Cells for the Treatment of Liver Diseases: Novel Concepts

    The authors conclude the current state of efforts to derive human induced pluripotent stem cells for potential use in the modeling and treatment of liver disease.
    [Cells Tissues Organs]

    Abstract

    INDUSTRY AND POLICY NEWS

    BeiGene Announces Acceptance of a Supplemental New Drug Application for Tislelizumab in Patients with Previously Treated Unresectable Hepatocellular Carcinoma in China

    BeiGene, Ltd. announced that the Center for Drug Evaluation of the China National Medical Products Administration has accepted a supplemental new drug application of BeiGene’s anti-PD-1 antibody tislelizumab for the treatment of patients with previously treated unresectable hepatocellular carcinoma, the most common form of liver cancer.
    [BeiGene, Ltd. (GlobeNewswire, Inc.)]

    Press Release

    DURECT Corporation Announces Initiation of Patient Recruitment in Phase II Safety and Efficacy Study of DUR-928 in COVID-19 Patients with Acute Liver or Kidney Injury

    DURECT Corporation announced it has initiated recruiting patients for its randomized, double-blind, placebo-controlled, multi-center Phase II study to evaluate the safety and efficacy of DUR-928 in hospitalized COVID-19 infected patients with acute liver or kidney injury.
    [DURECT Corporation]

    Press Release

    Amidst Uncertainty, Flexibility Is Key in Higher Ed, Faculty Say

    Life sciences professors and other staff make contingency plans for more coronavirus-related disruptions in the coming school year.
    [The Scientist]

    Editorial

    FEATURED EVENT

    Keystone eSymposia | Advances in Cancer Immunotherapy

    August 17 – August 19
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Oligonucleotide Chemist – Liver and CNS

    Deep Genomics – Toronto, Ontario, Canada

    Postdoctoral Scholarship – Molecular Metabolism

    University of Gothenburg – Gothenburg, Sweden

    Postdoctoral Research Scientist – Liver Diseases

    Columbia University Medical Center – New York, New York, United States

    Postdoctoral Scientist – Gene Editing in Liver Disease

    Beam Therapeutics – Cambridge, Massachusetts, United States

    Associate Professor – Hepatology

    Yale University – New Haven, Connecticut, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Hepatic Cell News Twitter